Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Viktor Chesnokov"'
Publikováno v:
Medicines, Vol 6, Iss 4, p 104 (2019)
Background: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively kills tumor cells in cancer patients. However, patients often develop TRAIL resistance; thus, agents that can sensitize cells to TRAIL therapy would be bene
Externí odkaz:
https://doaj.org/article/2d1670956ed649e4ac66a1c81767347f
Publikováno v:
Medicines
Volume 6
Issue 4
Medicines, Vol 6, Iss 4, p 104 (2019)
Volume 6
Issue 4
Medicines, Vol 6, Iss 4, p 104 (2019)
Background: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively kills tumor cells in cancer patients. However, patients often develop TRAIL resistance
thus, agents that can sensitize cells to TRAIL therapy would be
thus, agents that can sensitize cells to TRAIL therapy would be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c832faa5fbd98aa1e51475eb494e2b4f
https://doi.org/10.3390/medicines6040104
https://doi.org/10.3390/medicines6040104
Publikováno v:
Cancer Research. 79:2495-2495
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has attracted wide attention and extensive research because of selective apoptosis of tumor cells but not of normal cells. However, the clinical trials using TRAIL alone were disap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06622a5adba139eb0dc4b0a862525f80
https://doi.org/10.1158/1538-7445.am2019-2495
https://doi.org/10.1158/1538-7445.am2019-2495
Publikováno v:
Cancer Research. 77:4489-4489
AT-Rich Interaction Domain-containing protein 5a (ARID5A; also known as Modulator Recognition Factor 1(MRF1) ) was first cloned in our laboratory by screening a cDNA library of Tera-2 mRNA with an oligonucleotide probe from the major immediate early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8ca38d75845a2e9f36be5f07a79503e
https://doi.org/10.1158/1538-7445.am2017-4489
https://doi.org/10.1158/1538-7445.am2017-4489
Publikováno v:
Cancer Cell International
Background We have reported that the glucosamine suppressed the proliferation of the human prostate carcinoma cell line DU145 through inhibition of STAT3 signaling. DU145 cells autonomously express IL-6 and the IL-6/STAT3 signaling is activated. IL-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298d6166c3e558e4a96f237b23b6936a
https://doi.org/10.1186/1475-2867-14-45
https://doi.org/10.1186/1475-2867-14-45
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 9, Iss 1, p 25 (2009)
Cancer Cell International, Vol 9, Iss 1, p 25 (2009)
Background Glucosamine is known as a toxic agent for several malignant cell lines and transplanted tumors with little toxicity to normal host tissues. However, the mechanisms underlying anticancer activity of glucosamine are poorly understood. To stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f155317a7b434040646dd33e5f09fe9
https://doi.org/10.1186/1475-2867-9-25
https://doi.org/10.1186/1475-2867-9-25
Publikováno v:
Cancer Research. 74:1405-1405
AT-Rich Interaction Domain-containing protein 5a (ARID5A; also known as Modulator Recognition Factor 1(MRF1)) was first cloned in our laboratory by screening a cDNA library of Tera-2 mRNA with an oligonucleotide probe from the major immediate early g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bdeff46c2ab479f2b540874888d427f
https://doi.org/10.1158/1538-7445.am2014-1405
https://doi.org/10.1158/1538-7445.am2014-1405